Larimar Therapeutics Inc. sell ReynadJ
Start price
18.02.24
/
0%
€12.10
Target price
18.02.25
-
Performance (%)
-41.32%
Price
06.05.24
€7.35
Summary
This prediction is currently active. Massive losses of -41.32% have been the result for the SELL prediction by ReynadJ. This prediction currently runs until 18.02.25. The prediction end date can be changed by ReynadJ at any time. This prediction was marked as speculative and is excluded from ReynadJ's performance statistics.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Larimar Therapeutics Inc. | 22.500% | 22.500% |
| iShares Core DAX® | 0.476% | -0.039% |
| iShares Nasdaq 100 | 1.290% | 0.504% |
| iShares Nikkei 225® | 1.300% | -2.135% |
| iShares S&P 500 | 0.829% | 0.193% |
According to ReynadJ what are the pros and cons of Larimar Therapeutics Inc. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Bad rating
High valuation
Low dividend yield expected
negative Cash Flow expected
Little Investments for future growth
Comments by ReynadJ for this prediction
In the thread Zafgen Inc. diskutieren
Sell Larimar Therapeutics Inc.